Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2019
HIRA puts brakes on Gilead’s AIDS treatment receiving reimbursement
22 March 2019 - The reimbursement plan for Gilead Science Korea’s Biktarvy, an acquired immune deficiency syndrome (AIDS) treatment, has been ...
Posted by Michael Wonder on 25 Mar 2019
Canadian public places high priority on drugs’ safety, effectiveness, and certainty of evidence
25 March 2019 - Survey reveals top values for drug coverage decision making. ...
Posted by Michael Wonder on 25 Mar 2019
Eli Lilly sheds light on confidential drug pricing, discloses charges for popular diabetes medicine Humalog
25 March 2019 - Eli Lilly says the “net price” for insulin fell to $135 a patient a month in 2018 ...
Posted by Michael Wonder on 25 Mar 2019
Pharma fears “lack of focus” on no-deal Brexit preparations
22 March 2019 - As Brexit is delayed, pharma suggests new measures to avoid no-deal drugs shortages. ...
Posted by Michael Wonder on 25 Mar 2019
EMA publishes agenda for 25-28 March CHMP meeting
25 March 2019 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 25 Mar 2019
Rotorua teacher needs $100k for cancer drug to live longer for his young sons
26 March 2019 - Trainee teacher Whitinga Harris was in a classroom at Western Heights Primary School in October last ...
Posted by Michael Wonder on 25 Mar 2019
Cancer patients wait up to 12 weeks for urgent treatment
26 March 2019 - Dozens of cancer sufferers are waiting more than two months for urgent treatment. ...
Posted by Michael Wonder on 25 Mar 2019
Palmerston North mum appeals to PHARMAC for desperately needed drug
26 March 2019 - Wiki Mulholland, who has advanced breast cancer, is appealing to PHARMAC to get a $7,000 per month ...
Posted by Michael Wonder on 25 Mar 2019
Mavenclad (cladribine tablets) approved as the first short-course oral treatment for relapsing remitting multiple sclerosis in Switzerland
25 March 2019 - Approval based on extensive clinical development program capturing more than 10,000 patient years of safety data and ...
Posted by Michael Wonder on 25 Mar 2019
VAT cut on ‘orphan drugs’ will lift healthcare burden, but many still struggle to afford medication
24 March 2019 - China has reduced value-added tax (VAT) by 3% on 21 orphan drugs and four active pharmaceutical ingredients ...
Posted by Michael Wonder on 25 Mar 2019
China pledges stronger reform on approving, monitoring new drugs
23 March 2019 - China pledged to improve its system for registering new drugs in the country this year and ...
Posted by Michael Wonder on 25 Mar 2019
19,000 Australians now using PBS subsidised anti-HIV drugs
25 March 2019 - About 19,000 Australians have taken advantage of anti-HIV drugs in the first two years of groundbreaking ...
Posted by Michael Wonder on 25 Mar 2019
Melbourne's Peter MacCallum Cancer Centre to be home of 'the next great wave in treatment'
25 March 2019 - A new form of cancer treatment that uses cell therapy to attack the disease will become ...
Posted by Michael Wonder on 24 Mar 2019
As political scrutiny mounts, Eli Lilly divulges new insulin pricing data
24 March 2019 - Lilly says the price it was paid for popular insulin Humalog fell 8.1% from 2014 to 2018 ...
Posted by Michael Wonder on 24 Mar 2019
Drug prices on TV? They may be coming.
23 March 2019 - The Trump administration is moving ahead with its proposal to require drug companies to disclose the ...